Literature DB >> 20346306

Left ventricular function and C-reactive protein levels in acute myocardial infarction.

Adelaide M Arruda-Olson1, Maurice Enriquez-Sarano, Francesca Bursi, Susan A Weston, Allan S Jaffe, Jill M Killian, Véronique L Roger.   

Abstract

To examine left ventricular (LV) function in patients after acute myocardial infarction (AMI) and assess its relation to C-reactive protein (CRP) as a measure of the early inflammatory response. We measured the CRP levels early after AMI and correlated them with the early structural and functional cardiac alterations. From November 2002 to December 2007, we prospectively enrolled community subjects who had experienced an AMI, as defined by standardized criteria, measured the CRP level, and obtained an echocardiogram. The study consisted of 514 patients (mean age 67 +/- 15 years, 59% men). CRP was measured early after symptom onset (median 6.1 hours; twenty-fifth to seventy-fifth percentile 2.2 to 11.1). The median CRP level was 4.8 mg/L (twenty-fifth to seventy-fifth percentile 1.8 to 24). The echocardiograms were obtained at a median of 1 day after AMI. The wall motion score index, LV ejection fraction, and LV diameter were similar across the CRP tertiles (all p >0.05). Greater CRP levels were associated with the presence of moderate or severe diastolic dysfunction (p = 0.002) and moderate or severe mitral regurgitation (p <0.001). The association with moderate or severe mitral regurgitation was independent of the clinical characteristics and ST-segment elevation status. In conclusion, at the initial phase of AMI, CRP elevation was associated with the presence and severity of mitral regurgitation and diastolic dysfunction. This suggests that inflammation is related to the ventricular remodeling processes, independently of LV systolic function. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346306      PMCID: PMC2847591          DOI: 10.1016/j.amjcard.2009.11.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Redefinition of myocardial infarction: prospective evaluation in the community.

Authors:  Véronique L Roger; Jill M Killian; Susan A Weston; Allan S Jaffe; Jan Kors; Paula J Santrach; Hugh Tunstall-Pedoe; Steven J Jacobsen
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

2.  Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study.

Authors:  S F Yiu; M Enriquez-Sarano; C Tribouilloy; J B Seward; A J Tajik
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Significance of Doppler-detected mitral regurgitation in acute myocardial infarction.

Authors:  B Barzilai; C Gessler; J E Pérez; C Schaab; A S Jaffe
Journal:  Am J Cardiol       Date:  1988-02-01       Impact factor: 2.778

5.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

6.  Ischemic mitral regurgitation and risk of heart failure after myocardial infarction.

Authors:  Doron Aronson; Noa Goldsher; Robert Zukermann; Michael Kapeliovich; Jonathan Lessick; Diab Mutlak; Salim Dabbah; Walter Markiewicz; Rafael Beyar; Haim Hammerman; Shimon Reisner; Yoram Agmon
Journal:  Arch Intern Med       Date:  2006-11-27

7.  Incidence of heart failure after myocardial infarction: is it changing over time?

Authors:  Jens P Hellermann; Tauqir Y Goraya; Steven J Jacobsen; Susan A Weston; Guy S Reeder; Bernard J Gersh; Margaret M Redfield; Richard J Rodeheffer; Barbara P Yawn; Véronique L Roger
Journal:  Am J Epidemiol       Date:  2003-06-15       Impact factor: 4.897

8.  C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.

Authors:  Eric S Williams; Sanjiv J Shah; Sadia Ali; Bee Ya Na; Nelson B Schiller; Mary A Whooley
Journal:  Eur J Heart Fail       Date:  2007-12-21       Impact factor: 15.534

9.  Impact of serum C-reactive protein elevation on the left ventricular spherical change and the development of mitral regurgitation after anterior acute myocardial infarction.

Authors:  Takashi Kohno; Toshihisa Anzai; Kotaro Naito; Yohei Ohno; Hidehiro Kaneko; Hui-Chong Li; Yasuo Sugano; Yuichiro Maekawa; Shiro Iwanaga; Yasushi Asakura; Tsutomu Yoshikawa; Satoshi Ogawa
Journal:  Cardiology       Date:  2007-02-06       Impact factor: 1.869

10.  High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.

Authors:  Kohzou Uehara; Masahiro Nomura; Yuji Ozaki; Hiroyuki Fujinaga; Hiroyuki Ikefuji; Masaru Kimura; Kazumasa Chikamori; Yutaka Nakaya; Susumu Ito
Journal:  Heart Vessels       Date:  2003-05       Impact factor: 2.037

View more
  6 in total

1.  Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction.

Authors:  Iwona Swiatkiewicz; Marek Kozinski; Przemyslaw Magielski; Tomasz Fabiszak; Adam Sukiennik; Eliano Pio Navarese; Grazyna Odrowaz-Sypniewska; Jacek Kubica
Journal:  Mediators Inflamm       Date:  2012-09-02       Impact factor: 4.711

2.  Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.

Authors:  Iwona Swiatkiewicz; Marek Kozinski; Przemyslaw Magielski; Joanna Gierach; Tomasz Fabiszak; Aldona Kubica; Adam Sukiennik; Eliano Pio Navarese; Grazyna Odrowaz-Sypniewska; Jacek Kubica
Journal:  Inflamm Res       Date:  2012-03-24       Impact factor: 4.575

Review 3.  Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients.

Authors:  Sibo Tian; Kim M Hirshfield; Salma K Jabbour; Deborah Toppmeyer; Bruce G Haffty; Atif J Khan; Sharad Goyal
Journal:  Front Oncol       Date:  2014-10-09       Impact factor: 6.244

4.  Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure.

Authors:  Iwona Świątkiewicz; Przemysław Magielski; Jacek Kubica; Adena Zadourian; Anthony N DeMaria; Pam R Taub
Journal:  Int J Mol Sci       Date:  2020-01-26       Impact factor: 5.923

5.  Serum Biomarkers for Chemotherapy Cardiotoxicity Risk Detection of Breast Cancer Patients.

Authors:  Diya Hasan; Yazan Ismail; Ahmad Al Tibi; Safaa A Al-Zeidaneen; Mohanad Odeh; George J Burghel; Iyad Natsheh; Amid Abdelnour
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

Review 6.  Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer.

Authors:  James Meehan; Mark Gray; Carlos Martínez-Pérez; Charlene Kay; Lisa Y Pang; Jennifer A Fraser; Amy V Poole; Ian H Kunkler; Simon P Langdon; David Argyle; Arran K Turnbull
Journal:  Front Oncol       Date:  2020-04-24       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.